Come up with a name for your new list and we'll add to it:
Athera Biotechnologies raised a round of funding on June 19, 2013. Investors include
Seventh Framework Programme.
Athera Biotechnologies has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The lead product ca…